Low-dose CT scanning improves assessment of ankylosing spondylitis patients

(European League Against Rheumatism) The results of a study presented today at the Annual European Congress of Rheumatology 2017 showed that low dose computed tomography is more sensitive than conventional radiographs (X-rays) in the monitoring of disease progression in patients with Ankylosing Spondylitis (AS).
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news

Related Links:

Authors: Drissi Touzani K, Hilali O, Chraibi F, Abdellaoui M, Benatiya Andaloussi I PMID: 29903586 [PubMed - as supplied by publisher]
Source: Journal Francais d Ophtalmologie - Category: Opthalmology Tags: J Fr Ophtalmol Source Type: research
In conclusion, diagnosing HO is challenging for rheumatologists and physicians. Basic examinations of electrolyte balance and bone mineral density should be performed, as should tumor screening and a careful collection of patient medical history and drugs in young patients with unexplained thoracic or back pain and muscle weakness. Removing any secondary etiology, such as drugs may dramatically improve the patients clinical manifestations and result in an improved prognosis. PMID: 29904418 [PubMed]
Source: Experimental and Therapeutic Medicine - Category: General Medicine Tags: Exp Ther Med Source Type: research
To compare the efficacy of long and short segment instrumentation following pedicle subtraction osteotomy (PSO) for thoracolumbar kyphosis caused by ankylosing spondylitis (AS).
Source: World Neurosurgery - Category: Neurosurgery Authors: Tags: Original article Source Type: research
People with this painful condition that affects the spine are at higher risk of harming themselves, a large study confirms; however, the mental health effects of the disease are often ignored.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Source Type: news
Conditions:   Ankylosing Spondylitis;   Coxitis Intervention:   Drug: Golimumab Injection Sponsor:   MSD Pharmaceuticals LLC Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
CONCLUSION: Reproducibility of the UCOASMI seems very high, and apparently more reliable than conventional measures of mobility. PMID: 29907675 [PubMed - as supplied by publisher]
Source: J Rheumatol - Category: Rheumatology Authors: Tags: J Rheumatol Source Type: research
(European League Against Rheumatism) The results of a population study presented today at the Annual European Congress of Rheumatology (EULAR 2018) demonstrate a significantly increased rate of self-harm attempts in inflammatory arthritis (IA), particularly following a diagnosis of Ankylosing Spondylitis (AS).
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
(European League Against Rheumatism) The results of a cohort study presented at the Annual European Congress of Rheumatology (EULAR 2018) showed that, in patients with ankylosing spondylitis (AS) taking tumour necrosis factor (TNF) inhibitors, the addition of non-steroidal anti-inflammatory drugs (NSAIDs) was associated with significantly less radiographic progression in a dose-related manner at four years.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
Publication date: Available online 13 June 2018 Source:European Journal of Integrative Medicine Author(s): Xiu-Ling Wang, Ai-Ying Zhang, Wan-Shan Zhou Introduction Cupping therapy has been widely used in Eastern Asia, the Middle East, and Central and Northern Europe to manage the symptoms of ankylosing spondylitis (AS). The aim of this systematic review is to review data from randomized controlled trials (RCTs) of cupping therapy for treating patients with AS. Methods Databases that will be searched from their inception until February 2018: MEDLINE, CINAHL, EMBASE, AMED, Cochrane Central Register of Controlled Trials, six...
Source: European Journal of Integrative Medicine - Category: Complementary Medicine Source Type: research
Conditions:   Psoriatic Arthritis;   Ankylosing Spondylitis;   Non-Radiographic Axial Spondyloarthritis Interventions:   Drug: tildrakizumab 200 mg (two 1-mL injections of 100 mg/mL);   Drug: tildrakizumab 100 mg (one 1-mL injection of 100 mg/mL + 1 mL placebo) Sponsor:   Sun Pharma Global FZE Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Ankylosing Spondylitis | CT Scan | International Medicine & Public Health | PET Scan | Politics | Radiography | Rheumatology | Study | X-Ray